In the included patients, SGLT2 inhibitor therapy, age, GPT, LDL-C, T-CHO, HDL-C, and gout were significant factors for total cardiac arrhythmia incidence in the univariate analysis. The gene discussed is SLC5A2; the disease is cardiac rhythm disease.